These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


471 related items for PubMed ID: 29468284

  • 1. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
    Vartolomei MD, Kimura S, Ferro M, Vartolomei L, Foerster B, Abufaraj M, Shariat SF.
    World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
    [Abstract] [Full Text] [Related]

  • 2. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
    Vartolomei MD, Mathieu R, Margulis V, Karam JA, Rouprêt M, Lucca I, Mbeutcha A, Seitz C, Karakiewicz PI, Fajkovic H, Wood CG, Weizer AZ, Raman JD, Rioux-Leclercq N, Haitel A, Bensalah K, Rink M, Briganti A, Xylinas E, Shariat SF.
    World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
    [Abstract] [Full Text] [Related]

  • 3. The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
    Kishimoto N, Takao T, Kuribayashi S, Yamamichi G, Nakano K, Kawamura M, Tsutahara K, Tanigawa G, Yamaguchi S.
    Int J Clin Oncol; 2017 Feb; 22(1):153-158. PubMed ID: 27614622
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis.
    Mori K, Janisch F, Mostafaei H, Lysenko I, Kimura S, Egawa S, Shariat SF.
    Urol Oncol; 2020 May; 38(5):315-333. PubMed ID: 32088103
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
    Xu H, Tan P, Ai J, Huang Y, Lin T, Yang L, Wei Q.
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y, Li W, Wang D, Wu B.
    World J Surg Oncol; 2020 Oct 23; 18(1):273. PubMed ID: 33097052
    [Abstract] [Full Text] [Related]

  • 7. High Neutrophil-to-lymphocyte Ratio as Prognostic Factor in Patients Affected by Upper Tract Urothelial Cancer: A Systematic Review and Meta-analysis.
    Marchioni M, Cindolo L, Autorino R, Primiceri G, Arcaniolo D, De Sio M, Schips L.
    Clin Genitourin Cancer; 2017 Jun 23; 15(3):343-349.e1. PubMed ID: 28131752
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract.
    Kang M, Jeong CW, Kwak C, Kim HH, Ku JH.
    Clin Genitourin Cancer; 2017 Aug 23; 15(4):e633-e643. PubMed ID: 28174011
    [Abstract] [Full Text] [Related]

  • 9. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
    Tanaka N, Kikuchi E, Shirotake S, Kanao K, Matsumoto K, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Hayakawa N, Ito Y, Kosaka T, Kodaira K, Oyama M, Miyajima A, Momma T, Nakagawa K, Ueno M, Oya M.
    Eur Urol; 2014 Jan 23; 65(1):227-34. PubMed ID: 23219372
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
    Tanaka N, Kikuchi E, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakamura S, Oya M.
    BJU Int; 2013 May 23; 111(6):857-64. PubMed ID: 22757942
    [Abstract] [Full Text] [Related]

  • 11. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma.
    Otsuka M, Kamasako T, Uemura T, Takeshita N, Shinozaki T, Kobayashi M, Komaru A, Fukasawa S.
    Int J Urol; 2018 Oct 23; 25(10):871-878. PubMed ID: 30103271
    [Abstract] [Full Text] [Related]

  • 12. Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
    Dalpiaz O, Pichler M, Mannweiler S, Martín Hernández JM, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC.
    Br J Cancer; 2014 May 13; 110(10):2531-6. PubMed ID: 24691424
    [Abstract] [Full Text] [Related]

  • 13. The prognostic value of preoperative neutrophil-to-lymphocyte ratio in patients with upper tract urothelial carcinoma.
    Tan P, Xu H, Liu L, Ai J, Xu H, Jiang Y, Zhang X, Yang L, Wei Q.
    Clin Chim Acta; 2018 Oct 13; 485():26-32. PubMed ID: 29908941
    [Abstract] [Full Text] [Related]

  • 14. Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome.
    Luo HL, Chen YT, Chuang YC, Cheng YT, Lee WC, Kang CH, Chiang PH.
    BJU Int; 2014 May 13; 113(5b):E144-9. PubMed ID: 24274691
    [Abstract] [Full Text] [Related]

  • 15. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
    Luo Z, Jiao B, Huang T, Zhao H, Zhang G.
    Technol Cancer Res Treat; 2022 May 13; 21():15330338221095667. PubMed ID: 35585719
    [Abstract] [Full Text] [Related]

  • 16. Concomitant carcinoma in situ as a prognostic factor in the upper tract urothelial carcinoma after radical nephroureterectomy: A systematic review and meta-analysis.
    Gao X, Ma Y, Chen G, Chen J, Li H, Li H, Wei X, Wang K.
    Urol Oncol; 2020 Jun 13; 38(6):574-581. PubMed ID: 32273049
    [Abstract] [Full Text] [Related]

  • 17. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.
    Shibing Y, Liangren L, Qiang W, Hong L, Turun S, Junhao L, Lu Y, Zhengyong Y, Yonghao J, Guangqing F, Yunxiang L, Dehong C.
    BJU Int; 2016 Dec 13; 118(6):902-910. PubMed ID: 26935344
    [Abstract] [Full Text] [Related]

  • 18. Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.
    Mori K, Janisch F, Parizi MK, Mostafaei H, Lysenko I, Kimura S, Enikeev DV, Egawa S, Shariat SF.
    J Urol; 2020 Jun 13; 203(6):1075-1084. PubMed ID: 31479406
    [Abstract] [Full Text] [Related]

  • 19. A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma.
    Fang D, Seisen T, Yang K, Liu P, Fan X, Singla N, Xiong G, Zhang L, Li X, Zhou L.
    Eur J Surg Oncol; 2016 Nov 13; 42(11):1625-1635. PubMed ID: 27612412
    [Abstract] [Full Text] [Related]

  • 20. Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy.
    Mori K, Janisch F, Mostafaei H, Kimura S, Lysenko I, Karakiewicz PI, Briganti A, Enikeev DV, Rouprêt M, Margulis V, Chlosta P, Nyirady P, Babjuk M, Egawa S, Shariat SF.
    Urol Oncol; 2020 Jun 13; 38(6):601.e17-601.e24. PubMed ID: 32127252
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.